Perrigo Company plc

NYSE:PRGO   3:59:57 PM EDT
47.89
+0.55 (+1.16%)
Products

Vyne Therapeutics Says On June 30 Received A Paragraph IV Certification Notice From Perrigo Israel Pharmaceuticals

Published: 07/02/2021 22:39 GMT
Perrigo Company plc (PRGO) - Vyne Therapeutics - on June 30 Received a Paragraph Iv Certification Notice From Perrigo Israel Pharmaceuticals.
Vyne Therapeutics - Notice Advising Perrigo Submitted to U.S. FDA an Anda for Approval to Manufacture, Sell Generic Version of Co's Product Amzeeq.
Vyne Therapeutics - Notice Alleges Challenged Patents Are Invalid, Unenforceable, Will Not Be Infringed by Commercial Manufacture of Generic Product in Perrigo’s Anda.
Vyne Therapeutics - Currently Reviewing Notice & Intends to Vigorously Defend, Enforce Intellectual Property Rights Protecting Amzeeq, As Needed.
Further Company Coverage: Prgon ((reuters.
Briefs@thomsonreuters.
Com;)).